Literature DB >> 34836749

Gender distribution in boards of intensive care medicine societies.

Svenja Ravioli1, Nathalie Moser2, Basil Ryser3, Carmen Andrea Pfortmueller4, Gregor Lindner3.   

Abstract

PURPOSE: The established gender gap in intensive care medicine is larger compared to other medical specialties. The aim of this study was to evaluate gender distribution in boards of intensive care medicine societies worldwide.
METHODS: In this cross-sectional analysis, board members and presidents of all intensive care medicine societies associated with the European Society of Intensive Care Medicine were eligible for study inclusion. Exclusion criteria were: A) society without focus on intensive care and B) online information unavailable.
RESULTS: In 2021, 65 presidents and 820 board members were analyzed. Ten presidents (15%) and 231 board members (28%) were women. The proportion of women presidents reached from 0% in Africa to 20% in Europe and South America. The proportion of women board members was highest in North and South America with 42% and 46% respectively and lowest in Africa (21%) and Asia (10%). In Europe, 31% of board members were women and 35% in Australia/New Zealand. Among presidents, women were underrepresented in all continents while gender distribution among board members varied significantly between countries (p < 0.0001).
CONCLUSION: Our analysis reveals an inequality in gender distribution in the boards of national intensive care medicine societies which varies but persists for all global regions.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Critical care; Diversity; Gender; Gender disparities; Intensive care medicine

Mesh:

Year:  2021        PMID: 34836749     DOI: 10.1016/j.jcrc.2021.11.006

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  1 in total

1.  Equality in Recipients of Nephrology Awards from International Societies.

Authors:  Michael Haidinger; Svenja Ravioli; Gregor Lindner
Journal:  Kidney Med       Date:  2022-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.